Recent attention has focused on the significance of colonic Archaea in human health and energy metabolism. The main objectives of this study were to determine the associations among the number of fecal Archaea, body mass index (BMI), fecal short chain fatty acid (SCFA) concentrations, and dietary intakes of healthy humans. We collected demographic information, 3-d diet records, and breath and fecal samples from 95 healthy participants who were divided into 2 groups:
Introduction
Archaea, a domain of anaerobic microorganisms, represent 0.003-12% of the total endogenous anaerobic microbiota in the distal colon (1) . Archaea most commonly found in the human ecosystem belong to the Euryarchaeota phylum and include methanogenic Methanobrevibacter smithii, followed by Methanosphaera stadtmanae, which is infrequently detected (2) (3) (4) , as well as the recently identified Methanomassiliicoccus luminyensis (5) . Nonmethanogenic Archaea from the Crenarchaeota phylum and Halobacteriaceae (Euryarchaeota) have rarely been identified in human feces (6, 7) .
Methane is detected in breath and can be measured in 33-77% (8-12) of healthy adult populations who are therefore considered Archaea positive. Archaea coexist in a syntrophic relationship with hydrogen-producing bacteria and use hydrogen to reduce carbon dioxide to methane (13) , thus shifting fermentation to more oxidized end products such as acetate and increasing the total SCFA production and energy harvested (14) (15) (16) . A study in a mouse model illustrated that colonization with M. smithii leads to an increased utilization of dietary fiber and increased body fat (17) . However, it is unclear if the presence of Archaea influence host energy balance in healthy humans. In a preliminary study with 9 participants, Zhang et al. (18) observed significantly higher numbers of Archaea in obese individuals than in normalweight or post-gastric-by-pass individuals, but similar results have not been observed in other studies that found a lower concentration of M. smithii in obese compared with lean participants (19, 20) . Therefore, more studies are needed to investigate if Archaea play a role in obesity.
The factors that determine and promote the growth of Archaea in the human large bowel are not fully understood and may include colonic transit time (21) , pH, amount of fermentable substrate available, bile acids (22) , and colonic mixing/stirring (23) . Diet is an important determinant of gut microbiota composition (24) . It is unclear if the growth of Archaea in humans is affected by diet. Some studies suggest that differences in diet do not affect methane production, because it is largely dependent on substrates of endogenous origin (10, 25) . This is supported by the finding of methanogenic bacteria in a colostomy patient in the portion of the large intestine that was unconnected to the normal fecal stream (26) . On the other hand, studies have shown that exogenous substrates like lactulose in various doses (9, 27, 28) and dietary pentoses (12) can significantly increase breath methane production. Dietary intakes in Archaea-positive and Archaeanegative participants have not been compared before to our knowledge.
Therefore, this cross-sectional study aimed to compare BMI, dietary intakes, and fecal SCFA concentrations in participants with detectable Archaea (Arch+ve) 6 and those with undetectable Archaea (Arch-ve). We hypothesized that Arch+ve participants would have different dietary intakes and the presence of Archaea would modify colonic fermentation, leading to different fecal SCFA profiles and concentrations and BMI compared with Arch-ve participants. In this study, total Archaea were quantified using PCR primers that target both methanogenic and nonmethanogenic species and therefore represent the totality of intestinal Archaea in humans.
Methods
Ninety-five male or nonpregnant, nonlactating females >17 y old were recruited via advertisements posted around the University of Toronto campus and from a pool of participants previously involved in studies by our group. Participants were excluded for any of the following reasons: regular use of antibiotics ($1 course per year during the last 5 y); any use of antibiotics, laxatives, or other drugs known to influence gastrointestinal function in the 3 mo prior to the study; and presence of inflammatory bowel disease, malabsorption, gastrointestinal infection, short bowel, or other condition affecting gastrointestinal function or any recent (3 mo prior to the study) illness or surgery requiring hospitalization. This study was approved by the Research Ethics Board, University of Toronto. Written informed consent was obtained from all participants.
Participants were studied during 2 separate visits to the laboratory. At the first visit, they completed questionnaires related to demographics, medical history, drug use, and physical activity. ParticipantsÕ height and weight were measured and 2 breath samples were collected. Participants were given instructions on how to record their dietary intake and asked to keep a 3-d diet record. Participants were also given a fecal collection kit that consisted of the Fisherbrand commode specimen collection system (Fisher Scientific) and plastic bags. On the third day of the diet record or the day after, participants collected a fecal sample. The plastic bag containing the fecal sample was immediately placed on dry ice, brought to the laboratory within 24 h of being collected, and then stored at 220°C. At the second visit, participants returned the fecal sample and the dietary record and provided 2 more breath samples.
Breath samples were collected using the Easy Sampler with tube holder (Quintron Instrument). Methane and hydrogen were measured by GC (Quintron Microlyzer, Model SC) in breath samples and simultaneously obtained room air. The concentrations reported were corrected by subtracting the hydrogen and methane of room air.
The fecal sample was weighed and homogenized in a 400 series masticator for 1 min. Aliquots of feces were then transferred to individual vials for determination of pH and SCFAs and DNA extraction. Fecal pH was measured using a FE20 pH meter with a MT InLab Solids Pro electrode (Mettler-Toledo). Fecal SCFAs were analyzed by GC after the homogenized sample was diluted with copper sulfate and centrifuged. The supernatant was stored at 220°C before vacuum distillation (29) . Distillation was performed by using a 225-mL sample of the supernatant to which was added a 25-mL internal standard solution consisting of 1.25 mmol/L ethyl-butyric acid and 1.06 mol/L formic acid. An automatic sampler (HP 7673; Hewlett-Packard) was used to inject 1-mL aliquots of sample into a gas chromatograph (HP 5890 Series II; HewlettPackard) equipped with a direct-cool, on-column inlet, an Agilent HP-FFAP column (30-m 3 0.53-mm 3 1.0-mm film), Agilent 19095F-123 (Agilent Technologies Canada), and a flame ionization detector.
For enumeration of total Archaea in fecal samples, DNA was extracted from 100 mg of homogenized feces using the E.Z.N.A. Stool DNA Isolation kit (Omega Bio-tek) following the manufacturerÕs protocol modified to include a lysozyme digestion step (30 min, 37°C). Concentration and purity of the DNA were assessed with a ThermoscientificÕs Nanodrop 1000 spectrophotometer (Nanodrop Technologies). Archaea were enumerated in triplicate by quantitative real-time PCR using 50 ng of DNA, the TaqMan Gene Expression Master mix (Applied Biosystems), and a TaqMan custom assay targeting the archaeal 16S rRNA gene (Arc787f, Arc1059r, and Arc915probe) (15) in 10-mL reactions. Amplifications were performed in a 7900HT thermocycler equipped with a 384-well block using default conditions (Applied Biosystems). Data were converted into number of 16S rRNA gene copies/g wet feces by interpolation from a previously constructed standard curve. This standard curve had been obtained from 9 serial 10-fold dilutions of plasmid DNA prepared as previously described (30) . Briefly, M. smithii ATCC 35061 DNA (DSMZ) was amplified using primers Arch344F and Arch1389R targeting the archaeal 16S rRNA gene (31, 32) and cloned into the pGEM-T Easy vector system II (Promega), which was used to transform Escherichia coli JM109 High Efficiency Competent Cells (Promega). Plasmid DNA was extracted from positively transformed colonies and its concentration and purity were determined using a Thermoscientific Nanodrop. The amplicon was sequenced for confirmation by ACGT. The number of plasmid copies was determined as previously described (33, 34) .
The standard curve had a linear range spanning 8 logs of plasmid copies, an m approaching the ideal value of 23.3 (y = 23.3095x + 40.014), and a detection limit of 250 plasmid copies/reaction.
Intake of nutrients was calculated from the 3-d diet records using ESHA ResearchÕs Food Processor SQL, Version 10.9.0.
Statistical analysis of the independent variables was done using the StudentÕs t test (2-tailed) for unpaired data. The sensitivity and specificity of the breath methane test and the x 2 test was calculated using a computer spreadsheet (Microsoft Office Excel 2007). The association between 2 variables was tested by PearsonÕs correlation coefficient and linear regression using IBM SPSS Statistics Version 20. Differences with P values # 0.05 (2-tailed) were considered significant. The results are expressed as means 6 SEMs.
A principal component analysis (PCA) (IBM SPSS Statistics Version 20) was carried out to study whether distinct patterns could be discerned from the data in this study. The number of factors to be extracted was based on scree plot analysis, eigenvalues (factors with eigenvalues >1 were retained), and proportion of common variance explained (>10%). Varimax (orthogonal) rotation was used to obtain a set of independent interpretable factors. The resulting factor pattern was interpreted using factor loadings of >0.4. These analyses were initially carried out with all participants pooled. We subsequently ran the analysis within the 2 groups (Arch+ve and Arch-ve).
Results
Participants were divided into 2 groups based on the presence (Arch+ve, n = 37, or 39% of all participants) or absence (Arch-ve, n = 58, or 61% of all participants) of Archaea in their stool, as determined by qPCR ( Table 1) . The age range for Arch+ve participants was 20-67 y and was 18-60 y for Arch-ve. The proportion of Arch+ve and Arch-ve participants in the 18-to 50-y (34 vs. 66%) and 51-to 67-y (62.5 vs. 37.5%) age groups varied significantly (x 2 = 0.03). No significant differences in gender (x 2 = 0.84) were observed between the 2 groups (Table 1) . Participants were divided into groups based on ethnicity: Asian (South Asian, Chinese, Southeast Asian), Caucasian, Black, and Hispanic. The study participants were largely Caucasian (51.6%) and Asian (36.8%). The ethnic makeup of the 2 groups significantly differed (x 2 = 0.03) ( Table 1 ). The main differences were observed in the Caucasians and Asian participants, who comprised 68 and 19% of Arch+ve participants compared with 41 and 48% of Arch-ve participants, respectively (Table 1) . BMI did not differ between the Arch+ve and Arch-ve participants (Table 1 ). In the participants with BMI >25 kg/m 2 (n = 42), 43% were Arch+ve and 57% were Arch-ve, with no differences in BMI between the 2 groups (30.7 6 1.3 vs. 30.1 6 0.7; P = 0.69).
There was a positive correlation between age and breath methane and between the number of log Archaea 16S rRNA gene copies and breath methane in the Arch+ve group (Fig. 1) . The sensitivity and specificity of the breath methane test is shown in Table 2 . Measuring breath methane to identify participants harboring Archaea had a sensitivity of 62% and a specificity of 93%. The test had a positive predictive value of 85% and a negative predictive value of 79%.
Concentrations of the SCFAs were similar in the Arch+ve and Arch-ve groups except for valerate, which was significantly higher in the Arch+ve participants (Table 1 ). In the Arch+ve group, negative correlations were observed between total dietary fiber (TDF) intake and fecal concentrations of propionate, butyrate, valerate, and total SCFAs ( Table 3) The 2 groups were well matched for mean dietary intakes of energy and no significant differences were observed between Arch +ve and Arch-ve for macronutrient intakes (Supplemental Table 1 ) and micronutrient intakes (Supplemental Table 2 ), except for significantly higher selenium intake in the Arch-ve group (Supplemental Table 2 ). A positive correlation was observed between TDF intake and breath methane in the Arch+ve group (Fig. 1) .
The Arch+ve group of participants was further studied by dividing participants into 2 subgroups based on presence or absence of breath methane: detectable methane (Meth+ve) and undetectable methane (Meth-ve) ( Table 4) . Participants who were Meth+ve were significantly older than the Meth-ve participants (Table 4) and age was positively correlated with methane concentrations in this group (r = 0.49; P = 0.02). Participants who were Meth+ve had significantly lower breath hydrogen concentrations and significantly higher fecal pH and number of log Archaea 16S rRNA gene copies (Table 4) . Energy and macronutrient intakes did not significantly differ, except that Meth+ve participants had higher intakes of TDF/1000 kcal compared with Meth-ve participants (12.8 6 1.2 vs. 9.2 6 1.1; P = 0.04). A positive correlation was also observed between intake of TDF and breath methane (r = 0.64; P = 0.001). Table 5 displays the results of a PCA of the numerous variables in all the participants. A 4-factor solution, which was supported by the retention criteria described in ''Methods,'' explained 69.1% of the total variance (Table 5 ). These factors were interpreted as: 1) a diet factor, with positive loadings of energy, fat, available 
FIGURE 1 Relationships between breath methane concentrations and age (A), TDF (B)
, and log Archaea 16s rRNA gene (C) in Arch+ve participants. Arch+ve, detectable Archaea; TDF, total dietary fiber.
Archaea, dietary fiber, and SCFAs 1271 carbohydrate, protein, and TDF; 2) an SCFA 1 factor, with positive loadings of isovalerate, isobutyrate, valerate, and butyrate; 3) an Archaea factor, with positive loadings of age, breath methane, TDF, TDF/1000 kcal, and number of log Archaea 16SrRNA gene copies; and 4) an SCFA 2 factor, with positive loadings of acetate, propionate, butyrate, and BMI. We also explored the possibility of a 5-factor solution; however, this solution was rejected, because they did not meet any of the evaluation criteria described in ''Methods.'' PCA was also performed in the Arch+ve and Arch-ve participants; the factor loadings were similar to those obtained in the whole group (Supplemental Tables 3 and 4 ).
Discussion
The results do not support a role for Archaea in human obesity in that the dietary intakes, BMI, and fecal concentrations of the major SCFAs were similar in Arch+ve and Arch-ve participants. However, the associations among TDF, breath methane, and SCFAs in the Arch+ve participants and the identification by PCA of a distinct Archaea factor suggest that their presence in significant numbers influences colonic fermentation and the profile of metabolic end products. The protective role of dietary fiber in lowering disease risk may be mediated via the beneficial effects attributed to SCFAs (35, 36) . Butyrate is an important source of energy for colonocytes and also has potent antitumoregenic properties (37) . Propionate is largely taken up by the liver and acetate reaches the peripheral circulation, where it can contribute to lipid and cholesterol synthesis. It is unclear if the presence of Archaea alters the amount and profile of SCFAs produced in the colon. In pure cultures of rumen bacteria, the presence of methane-producing bacteria enhanced acetate production from other species (14) . Few human studies have looked at fecal SCFAs in Archaea+ve and Archaea-ve individuals. Weaver et al. (38) observed that methanogenesis was accompanied by less propionate and more acetate production.
We found that methane production was associated with increased acetate production from lactulose, but not from rhamnose, cornstarch, guar, or ileostomy effluent (39) . In the present study, the higher fecal valerate concentrations in Arch+ve participants may be a result of a syntrophic relationship between Archaea and other colonic bacteria (40) , possibly Prevotellaceae (17). However, the presence of Archaea did not influence the concentration of the 3 major fecal SCFAs. The negative correlations between breath methane and fecal SCFA concentrations observed in the Arch+ve participants is consistent with Abell et al. (41), who found a negative correlation between mean fecal butyrate and methanogen abundance. The inverse association between breath methane and fecal SCFA concentrations could be due to increased absorption of SCFA in Arch+ve participants (42) . In addition, there may be cross-feeding with Archaea-associated bacteria, which may utilize SCFAs as an energy substrate. These findings are important, because they suggest that SCFA metabolism may differ in Arch+ve and Arch-ve individuals. The negative correlations between TDF and fecal SCFA that were only observed in the Arch+ve participants point to an interrelationship among TDF, Archaea, and SCFAs. More research to investigate SCFA production and absorption in Arch+ve and Arch-ve groups is warranted.
High dietary fiber intakes are associated with reduced risk for obesity (43) (44) (45) (46) . It was also recently suggested that the presence of colonic Archaea may contribute to obesity by increasing the efficiency of colonic fermentation (17) . However, the latter explanation does not appear to be consistent with the protective effect of high fiber intakes, which would also increase colonic fermentation. Zhang et al. (18) observed higher numbers of Archaea in an obese group of participants who had a mean BMI of 48.3 6 7.7 kg/m 2 compared with normal-weight and post-gastric-by-pass participants. In a recent study in obese participants, the methanepositive participants (BMI: 45.2 6 2.3 kg/m 2 ) had a significantly higher BMI than methane-negative participants (BMI: 38.5 6 0.8 kg/m 2 ) (47), perhaps suggesting that Archaea may have a role to play in severely and morbidly obese humans. We found that the presence of Archaea was not associated with increased BMI. More studies in larger groups are warranted to determine the role of Archaea in human obesity.
Age was positively associated with breath methane concentration. Almost twice as many participants >50 y of age were Arch+ve compared with those <50 y (62.5 vs. 34%). This effect of age on methanogenesis was also observed in an earlier study (8) . Age-related changes in gastrointestinal tract physiology (or function), e.g., slower colonic transit times (48) or lactose malabsorption (49), may promote Archaea growth and lead to increased breath methane. Age-associated dietary and host immune system modifications may also be involved. Our results may also be explained by an age-associated increase in diversity of methanogens (50) . A new order of methanogens with 4 new phylotypes was detected that grouped with Mx-01 and was more frequently detected in elderly people (50) . The presence of Archaea may also be related to ethnic origins (9) . Future studies should explore the effects of ethnic origins on Archaea carriage rates. Because 38% of Arch+ve participants had no detectable breath methane despite having detectable Archaea, the Arch+ve participants were divided into subgroups of Meth+ve and Meth-ve and compared. The Meth+ve participants were significantly older, had significantly higher Archaea 16S rRNA gene copies, and had higher intakes of TDF/1000 kcal and a higher fecal pH. In the Meth+ve group, significant correlations were also observed between age and breath methane and among TDF, TDF/1000 kcal, and breath methane. The higher intake of TDF and its positive association with breath methane was previously observed (51) and indicates that TDF may positively affect growth of Archaea. In summary, in the Meth+ve group, many factors (age, TDF, and more neutral fecal pH) seem to coexist that may make conditions conducive for Archaeal growth in the colon. The PCA also identified a distinct Archaea factor. Together, these results suggest that an interrelationship exists among age, TDF intakes, breath methane, and Archaea.
The positive association between Archaea 16S rRNA gene copies in fecal samples and breath methane might seem obvious, but to our knowledge, it has not been reported in studies to date. Stewart et al. (52) quantified methanogens using real-time PCR and measured breath methane but did not report any associations. Past studies (11, 53) have enumerated methanogens using anaerobic techniques and studied associations with breath methane, but no correlation between breath methane and estimates of fecal methanogens was observed. The present study shows that breath methane and fecal Archaea are positively associated. However, given the 62% sensitivity of the breath methane test, measuring breath methane alone may underestimate the number of participants harboring Archaea; our results are consistent with the previous suggestion that methane is detected in the breath only if the Archaea count is >10 8 /g dry weight (25) . The detection limit of the real-time PCR method in our study for Archaea 16S rRNA gene copies was log 3, but none of our participants had Archaea 16S rRNA gene copies <log 5. In this study in healthy human participants, the carriage rate for Archaea was 39%. This compares well with carriage rates for methanogens observed in other studies using molecular phylogenetic techniques (41, 52, 54) . However, in a recent study employing real-time PCR targeting M. smithii and M. stadtmanae 16S rRNA and rpoB genes, a prevalence rate of 95.5% was observed (55) . Studies have also detected nonmethanogenic Archaea in humans (6, 7) ; it may therefore be useful for future studies to specifically quantify methanogenic Archaea, e.g., by targeting the functional gene mcrA encoding for methyl coenzyme-M reductase.
In conclusion, our results show that the presence of Archaea is not related to BMI in healthy humans. Important associations among age, TDF, Archaea, breath methane, and SCFAs were observed that are important and need to be further studied. The results also point to associations between Archaea and SCFAs that suggest an altered SCFA metabolism in individuals harboring Archaea. More in-depth studies comparing SCFA metabolism and microbial profiles in the Arch+ve and Arch-ve groups are warranted. 
